» Articles » PMID: 26741401

The Role of PfEMP1 As Targets of Naturally Acquired Immunity to Childhood Malaria: Prospects for a Vaccine

Overview
Journal Parasitology
Specialty Parasitology
Date 2016 Jan 8
PMID 26741401
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

The Plasmodium falciparum erythrocyte membrane protein 1 antigens that are inserted onto the surface of P. falciparum infected erythrocytes play a key role both in the pathology of severe malaria and as targets of naturally acquired immunity. They might be considered unlikely vaccine targets because they are extremely diverse. However, several lines of evidence suggest that underneath this molecular diversity there are a restricted set of epitopes which may act as effective targets for a vaccine against severe malaria. Here we review some of the recent developments in this area of research, focusing on work that has assessed the potential of these molecules as possible vaccine targets.

Citing Articles

Population genetic analysis of Plasmodium vivax vir genes in Pakistan.

Dinzouna-Boutamba S, Moon Z, Lee S, Afridi S, Le H, Hong Y Parasites Hosts Dis. 2024; 62(3):313-322.

PMID: 39218630 PMC: 11366537. DOI: 10.3347/PHD.24036.


Detection of naturally acquired, strain-transcending antibodies against rosetting strains in humans.

McLean F, Azasi Y, Sutherland C, Toboh E, Ansong D, Agbenyega T Infect Immun. 2024; 92(7):e0001524.

PMID: 38842304 PMC: 11238554. DOI: 10.1128/iai.00015-24.


Different PfEMP1-expressing Plasmodium falciparum variants induce divergent endothelial transcriptional responses during co-culture.

Othman B, Zeef L, Szestak T, Rchiad Z, Storm J, Askonas C PLoS One. 2023; 18(11):e0295053.

PMID: 38033133 PMC: 10688957. DOI: 10.1371/journal.pone.0295053.


Mechanism of Immune Evasion in Mosquito-Borne Diseases.

Bhattacharjee S, Ghosh D, Saha R, Sarkar R, Kumar S, Khokhar M Pathogens. 2023; 12(5).

PMID: 37242305 PMC: 10222277. DOI: 10.3390/pathogens12050635.


Host-parasite interactions during infection: Implications for immunotherapies.

Chandley P, Ranjan R, Kumar S, Rohatgi S Front Immunol. 2023; 13:1091961.

PMID: 36685595 PMC: 9845897. DOI: 10.3389/fimmu.2022.1091961.


References
1.
Warimwe G, Fegan G, Musyoki J, Newton C, Opiyo M, Githinji G . Prognostic indicators of life-threatening malaria are associated with distinct parasite variant antigen profiles. Sci Transl Med. 2012; 4(129):129ra45. PMC: 3491874. DOI: 10.1126/scitranslmed.3003247. View

2.
Whitrow M . Wagner-Jauregg and fever therapy. Med Hist. 1990; 34(3):294-310. PMC: 1036142. DOI: 10.1017/s0025727300052431. View

3.
Clausen T, Christoffersen S, Dahlback M, Langkilde A, Jensen K, Resende M . Structural and functional insight into how the Plasmodium falciparum VAR2CSA protein mediates binding to chondroitin sulfate A in placental malaria. J Biol Chem. 2012; 287(28):23332-45. PMC: 3390611. DOI: 10.1074/jbc.M112.348839. View

4.
Gupta S, Snow R, Donnelly C, Newbold C . Acquired immunity and postnatal clinical protection in childhood cerebral malaria. Proc Biol Sci. 1999; 266(1414):33-8. PMC: 1689649. DOI: 10.1098/rspb.1999.0600. View

5.
Tebo A, Kremsner P, Piper K, Luty A . Low antibody responses to variant surface antigens of Plasmodium falciparum are associated with severe malaria and increased susceptibility to malaria attacks in Gabonese children. Am J Trop Med Hyg. 2003; 67(6):597-603. DOI: 10.4269/ajtmh.2002.67.597. View